Although cancer-associated fibroblasts (CAFs) are crucial stromal cells, characterizing their heterogeneity is far from complete. This study reports a novel subset of CAFs in oral squamous cell carcinoma (OSCC), which positively expressed CD68, the classic marker of macrophages. The spatial and temporal distribution of the CD68 þ CAF subset of OSCC (n Z 104) was determined by CD68/actin alpha 2, smooth muscle (ACTA2þ; a-SMA) immunohistochemistry of serial sections. The CD68 þ a-SMA þ CAF subset was elevated from dysplasia to OSCC. Moreover, although both the tumor center and invasive front harbor an abundant CD68 þ CAF subset, patients with low-CD68 þ CAFs in the tumor center showed more recurrence after operation and shorter survival time, indicating the different function of CD68 þ CAFs in tumor initiation and progression. Functional analysis in the OSCCeCAF co-culture system found knockdown of CD68 did not change the phenotype of CAFs, tumor growth, or migration. Unexpectedly, low-CD68 þ CAFs were associated with aberrant immune balance. A high proportion of tumor-supportive Tregs was found in patients with low-CD68 þ CAFs. Mechanistically, knockdown of CD68 in CAFs contributed to the up-regulation of chemokine CCL17 and CCL22 of tumor cells to enhance Treg recruitment. Thus, up-regulated CD68 þ fibroblasts participate in tumor initiation, but the low-CD68 þ CAF subset in OSCC is conducive to regulatory T-cell (Treg) recruitment in the tumor microenvironment and contribute to poor prognosis of OSCC patients.